According to ZF calculations, this corresponds to a 2.68% stake in Antibiotice Iasi and the deal amounted to RON10.62 million.
Previously, SIF Oltenia notified Antibiotice on its reaching the 26.05% ownership threshold in Antibiotice. According to ZF calculations based on the current trading price, SIF5’s investments in Antibiotice have reached around RON98 million.
Antibiotice Iasi has a stock market capitalization of RON374.6 million and is 53% held by the Health Ministry, while SIF Oltenia owns 23% in its shares.
The company reported sales of RON161.4 million in the first half of 2021, up 10.2% from the same period in 2020.
In January-June 2021, the company had a net profit of RON19.3 million, up nearly 1% on the year.
(English version by Catalina Apostoiu)